1030 Targeting Rho GTPases RAC1 and CDC42 in Advanced Prostate Cancer Cells

IF 2.5 4区医学 Q3 PHARMACOLOGY & PHARMACY

Journal of the American Pharmacists Association Pub Date : 2025-09-01 DOI:10.1016/j.japh.2025.102519

WF Fonseca Ferrer , AP Lopez Gonzales , CJ Díaz Osterman , CR Soto , C. Vlaar , E.P. Padro de Lemos , J.C. Gonzales , S. Dharmawardhane , V.T. Matos

引用次数: 0

查看原文本刊更多论文

1030靶向Rho GTPases， RAC1和CDC42在晚期前列腺癌细胞中的作用

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the American Pharmacists Association 医学-药学

CiteScore

3.30

自引率

14.30%

发文量

336

审稿时长

46 days

期刊介绍： The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.